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Where Are We Now? N ontraumatic osteonecrosis of the femoral head (ONFH) is a clinically important pathologic process that leads to pain and disability and often results in hip replacement. It is known to be associated with long-term use of corticosteroids, alcohol abuse, and coagulopathies [4, 7, 10] . However, its pathogenesis remains poorly understood, and several biological mechanisms have been suggested, including interruption of extraosseous blood supply to the femoral head by multiple nontraumatic stresses, intraosseous hypertension by altered lipid metabolism and its accumulation to the femoral head, and intravascular coagulopathies with various causes [3, 8, 9] . Endothelial (progenitor) cell dysfunction and inadequate nitric oxide production, which is known to be associated with atherosclerosis and the development of major adverse cardiovascular and cerebrovascular events (MACCE), may also be associated with ONFH [1, 5, 11] .
The current study by Sung and colleagues [12] helps us better understand the relationship between MACCE and ONFH, and in it, the authors suggest that a mechanism could be a shared pathophysiology between MACCE and ONFH, such as endothelial (progenitor) cell dysfunction, although in an observational study of this sort, there is no way to prove this contention.
Where Do We Need to Go?
A deeper investigation into the relationship between ONFH and MACCE is needed with more-detailed patientrelated variables such as personal history, demographics, socioeconomic status, lifestyle, and general medical and healthrelated status. We also need more information regarding the relationship between ONFH and MACCE, if there is one. It is not clear whether ONFH is the cause or effect of MACCE, or whether both have a common cause, such as endothelial (progenitor) cell dysfunction or the inadequate production of nitric oxide, for example. Observational studies will not answer this question; only mechanistic studies can provide the answers we seek on this important question.
Researchers should also examine in more-quantitative ways the possible relationship between ONFH and MACCE. More data on this relationship particularly regarding the incidence or prevalence of the two diseases and presence of common risk factors could help researchers determine the likelihood of a patient with ONFH developing MACCE or vice versa.
How Do We Get There?
Experimental studies in animal models are needed to better understand the [2] .
Additionally, mechanical studies in patients with ONFH are needed to clarify how much the endothelial cell dysfunction decreases and how its levels account for the severity of ONFH. We could achieve this by measuring the level of endothelial nitric oxide synthase and/or several endothelial-derived mediators such as nitric oxide [6] . We could then compare this data to a normal control group without ONFH. This type of study should be done in patients with MACCE as well, working in conjunction with cardiovascular medical groups.
Finally, both the clinical and mechanical studies mentioned above should be done in other populations or settings to determine whether the findings can be replicated. Clinical studies should focus on the association between ONFC and MACCE and mechanical studies should verify the decreases associated with endothelial cell dysfunction and reduced nitric oxide levels in patients with ONFH.
